From: Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children
Characteristics | Control group (n = 63) | Research group (n = 21) | P value |
---|---|---|---|
Hospital stay (day), median | 8.0 (3–15) | 9.0 (3–12) | 0.069 |
Fever days before admission, median | 7 (0–46) | 9 (3–21) | 0.449 |
Fever duration (day), median | 9 (2–29) | 12 (7–26) | 0.028 |
Max temperature (°C), median | 39.5 (37.8–41.0) | 39.8 (38.0–40.5) | 0.255 |
Heart rate (bpm), mean | 112 ± 13 (80–142) | 117 ± 14 (88–148) | 0.134 |
Respiratory rate (bpm), median | 25 (18–44) | 25 (21–56) | – |
Disturbance of consciousness, n | 0 | 1 (4.8%) | 0.25 |
Cyanosis, n | 1 (1.6%) | 0 | 0.75 |
Dyspnea, n | 1 (1.6%) | 4 (19%) | 0.013 |
Abnormal breath sounds, n | 39 (61.9%) | 14 (66.7%) | 0.797 |
Leukocyte count (× 10^9/L), median | 7.49 (2.9–20.42) | 5.95 (3.78–13.88) | 0.614 |
Anemia, n | 11 (17.5%) | 6 (28.6%) | 0.213 |
Platelet (× 10^9/L), mean | 323 ± 117 (90–622) | 238 ± 70 (111–342) | < 0.001 |
C-reactive protein> 8 mg/L, n | 34 (54.0%) | 12 (57.1%) | 0.502 |
Elevated serum CK-MB, n | 2 (3.2%) | 2 (9.5%) | 0.264 |
Multilobar infiltrates, n | 42 (66.7%) | 13 (61.9%) | 0.442 |
Pleural effusion, n | 17.0 (27%) | 7 (33.3%) | 0.383 |
Rash, n | 4 (4.3%) | 0 | 0.309 |
Myocardial damage, n | 22 (34.9%) | 6 (28.6%) | 0.4 |
Liver damage, n | 9 (14.3%) | 1 (4.8%) | 0.226 |
Fiberoptic bronchoscopy | 39 (61.9%) | 9 (42.9%) | 0.102 |
Oxygen therapy | 38 (60.3%) | 19 (90.5%) | 0.008 |
NCPAP | 0 | 2 (9.5%) | 0.06 |
Readmission | 6 (9.5%) | 2 (9.5%) | 0.683 |
Severe CAP | 49 (77.8%) | 17 (81.0%) | 0.512 |
Extremely severe pneumonia | 3 (4.8%) | 4 (19%) | 0.062 |
Severe disease defined by clinical score system | 8 (12.7%) | 9 (42.9%) | 0.005 |